Hoth Therapeutics Inc
NASDAQ:HOTH
Hoth Therapeutics Inc
NASDAQ:HOTH
Price:
0.8987
USD
1.4%
Market Cap:
$13.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hoth Therapeutics Inc
NASDAQ:HOTH
|
US |
|
Muyuan Foods Co Ltd
SZSE:002714
|
CN |
|
S
|
Stanley Agricultural Group Co Ltd
SZSE:002588
|
CN |
|
Tjk Machinery Tianjin Co Ltd
SZSE:300823
|
CN |
|
C
|
CuroHoldings Co Ltd
KOSDAQ:051780
|
KR |
|
Veeko International Holdings Ltd
HKEX:1173
|
HK |
|
Country Garden Services Holdings Co Ltd
HKEX:6098
|
CN |
|
L
|
Limelight Networks Inc
F:LNK
|
US |
|
Deutsche EuroShop AG
XETRA:DEQ
|
DE |
|
Amcor PLC
NYSE:AMCR
|
UK |
|
Winner Medical Co Ltd
SZSE:300888
|
CN |
|
Sampoerna Agro Tbk PT
IDX:SGRO
|
ID |
|
T
|
TKMS GmbH
XETRA:TKMS
|
DE |
|
Haima Automobile Co Ltd
SZSE:000572
|
CN |
|
T
|
Tonies SE
XETRA:TNIE
|
LU |
|
W
|
White Horse Bhd
KLSE:WTHORSE
|
MY |
|
Beijer Alma AB
STO:BEIA B
|
SE |
|
Delta Resources Ltd
XTSX:DLTA
|
CA |
|
J
|
JATT Acquisition Corp
F:1GU
|
KY |
|
S
|
Songz Automobile Air Conditioning Co Ltd
SZSE:002454
|
CN |
Income Statement
Earnings Waterfall
Hoth Therapeutics Inc
Hoth Therapeutics Inc
Income Statement
Hoth Therapeutics Inc
Hoth Therapeutics Inc
Currency: USD
| Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||
| Operating Expenses |
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(8)
|
(9)
|
(10)
|
(10)
|
(7)
|
(10)
|
(10)
|
(12)
|
(14)
|
(12)
|
(12)
|
(11)
|
(11)
|
(11)
|
(10)
|
(9)
|
(8)
|
(8)
|
(7)
|
(8)
|
(8)
|
(10)
|
(10)
|
(12)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(5)
|
(5)
|
(6)
|
(6)
|
(4)
|
(5)
|
(6)
|
(5)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
|
| Research & Development |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(6)
|
(8)
|
(7)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(5)
|
(5)
|
(6)
|
|
| Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(2)
N/A
|
(3)
-12%
|
(3)
-12%
|
(3)
-18%
|
(4)
-33%
|
(8)
-76%
|
(9)
-13%
|
(10)
-14%
|
(10)
-5%
|
(7)
+30%
|
(10)
-34%
|
(10)
-7%
|
(12)
-10%
|
(14)
-22%
|
(12)
+11%
|
(12)
+7%
|
(11)
+5%
|
(11)
0%
|
(11)
+4%
|
(10)
+6%
|
(9)
+6%
|
(8)
+18%
|
(8)
+2%
|
(7)
+1%
|
(8)
-1%
|
(8)
-9%
|
(10)
-17%
|
(10)
-6%
|
(12)
-19%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(2)
N/A
|
(3)
-12%
|
(3)
-12%
|
(3)
-18%
|
(4)
-33%
|
(8)
-76%
|
(9)
-13%
|
(10)
-14%
|
(10)
-4%
|
(7)
+31%
|
(10)
-34%
|
(10)
-8%
|
(12)
-11%
|
(14)
-23%
|
(13)
+12%
|
(12)
+5%
|
(11)
+5%
|
(11)
N/A
|
(11)
+3%
|
(10)
+7%
|
(10)
+5%
|
(8)
+18%
|
(8)
+2%
|
(7)
+3%
|
(8)
-1%
|
(8)
-9%
|
(10)
-17%
|
(10)
-6%
|
(12)
-19%
|
|
| Net Income | ||||||||||||||||||||||||||||||
| Income from Continuing Operations |
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(8)
|
(9)
|
(10)
|
(10)
|
(7)
|
(10)
|
(10)
|
(12)
|
(14)
|
(13)
|
(12)
|
(11)
|
(11)
|
(11)
|
(10)
|
(10)
|
(8)
|
(8)
|
(7)
|
(8)
|
(8)
|
(10)
|
(10)
|
(12)
|
|
| Net Income (Common) |
(2)
N/A
|
(3)
-12%
|
(3)
-12%
|
(3)
-18%
|
(4)
-33%
|
(8)
-76%
|
(9)
-13%
|
(10)
-14%
|
(10)
-4%
|
(7)
+31%
|
(10)
-34%
|
(10)
-8%
|
(12)
-11%
|
(14)
-23%
|
(13)
+12%
|
(12)
+5%
|
(11)
+5%
|
(11)
N/A
|
(11)
+3%
|
(10)
+7%
|
(10)
+5%
|
(8)
+18%
|
(8)
+2%
|
(7)
+3%
|
(8)
-1%
|
(8)
-9%
|
(10)
-17%
|
(10)
-6%
|
(12)
-19%
|
|
| EPS (Diluted) |
-11.14
N/A
|
-12.5
-12%
|
-9.96
+20%
|
-8.68
+13%
|
-10.95
-26%
|
-20.81
-90%
|
-21.24
-2%
|
-20.28
+5%
|
-19.18
+5%
|
-14.69
+23%
|
-13.57
+8%
|
-10.96
+19%
|
-12.08
-10%
|
-16.07
-33%
|
-13.15
+18%
|
-9.7
+26%
|
-8.81
+9%
|
-9.47
-7%
|
-4.42
+53%
|
-3.08
+30%
|
-2.76
+10%
|
-2.3
+17%
|
-1.75
+24%
|
-1.08
+38%
|
-1.08
N/A
|
-1.28
-19%
|
-0.75
+41%
|
-0.77
-3%
|
-0.88
-14%
|
|
Switch to:
Switch to:
See Also
Discover More
